Here’s what UK shares Manolete Partners and Marlowe reported today

The Marlowe and Manolete Partners share prices are edging higher in midweek business. Here’s why these UK shares are rising again.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

These two UK shares released all-new trading statements on Wednesday. Here’s the key information investors need to know.

A rising UK share

Shares in insolvency litigation specialist Manolete Partners (LSE: MANO) have halved in value over the past 12 months. This is because a strong economic recovery in the UK, and significant government support to ailing businesses, has hit the number of new cases experienced by the firm.

But Manolete’s share price edged 1% higher on Wednesday following the publication of full-year financials.  Revenues soared 49% during the financial year to March, to £27.8m. Meanwhile, Manolete’s retailed share of gross cash from completed cases rocketed 113% to £6.8m. And the UK legal share completed on a record 135 insolvency cases last year. It made 198 new case investments too, another all-time record.

The impact of that government assistance, along with increased staffing costs and a reassessment of the value of in-process cases during the pandemic, caused pre-tax profit to slump 26% to £7m. But Manolete expects the number of cases to rise as Covid-19 lockdown measures are rolled back and the government’s emergency suppression of insolvencies ends in September.

With the widely reported large backlog of insolvency cases, we expect new case enquiries to increase over the foreseeable future and we will continue working hard to deliver outstanding returns to both the creditors of insolvent estates and our investors,” Manolete commented.

Good momentum

The Marlowe (LSE: MRL) share price has fared much better than Manolete Partners during the past 12 months. The UK health and safety share has ballooned almost 80% in value as its aggressive approach to M&A has paid off. The business rose 1% on Wednesday too following the release of its own full-year financials.

Revenues rocketed 15% year-on-year during the 12 months to March, to £192m. And margins rose to 16.2%, from 13.1% previously. This was thanks to the positive impact of acquisitions, steps taken to improve productivity, and the leveraging its back-office infrastructure. All this meant that pre-tax profit soared 31% over the period to £17.1m.

Marlowe – which provides safety and compliance software and services — noted too that current 12-month run-rate revenues sit at £280m, 83% of which is recurring in nature. The company made 15 acquisitions in total last year and has continued spending heavily on M&A to supercharge future earnings growth. It’s made a further eight acquisitions since April to improve its presence in key markets.

Today, Marlowe affirmed its plan to generate run-rate revenues of £500m and adjusted EBITDA of £100m by financial 2024. The UK share said it hopes to achieve this “through deepening our market share across our sectors, broadening our activities across the business-critical arena, strengthening our business via operational improvements and delivering on our digital strategy.

And for the current financial year? Marlowe said it’s enjoyed a “strong start” with “good” levels of organic growth in the high-single-digit percentages across its businesses.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Marlowe. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Photo of a man going through financial problems
Investing Articles

Is a stock market crash coming? And what should I do now?

Global investors are panicking about a new US stock market crash in the days or weeks ahead. Here's how I'm…

Read more »

Investing Articles

FTSE shares: a brilliant opportunity for investors to get rich?

With valuations in the US looking full, Paul Summers thinks there's a good chance that FTSE stocks might become more…

Read more »

Growth Shares

2 FTSE 100 stocks that could outperform the index in 2025

Jon Smith flags up a couple of FTSE 100 stocks that have strong momentum right now and have beaten the…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

1 stock market mistake to avoid in 2025

This Fool has been battling bouts of of FOMO recently, as one of his growth shares enjoys a big bull…

Read more »

Investing Articles

2 no-brainer buys for my Stocks and Shares ISA in 2025

Harvey Jones picks out a couple of thriving FTSE 100 companies that he's keen to add to his Stocks and…

Read more »

Number three written on white chat bubble on blue background
Investing For Beginners

3 investing mistakes to avoid when buying UK shares for 2025

Jon Smith flags up several points for investors to note when it comes to thinking about which UK shares to…

Read more »

Investing Articles

Will the rocketing Scottish Mortgage share price crash back to earth in 2025?

The recent surge in the Scottish Mortgage share price caught Harvey Jones by surprise. He was on the brink of…

Read more »

Investing Articles

2 cheap shares I’ll consider buying for my ISA in 2025

Harvey Jones will be on the hunt for cheap shares for his ISA in 2025 and these two unsung FTSE…

Read more »